ESIF:XETRA:XETRA-iShares MSCI Europe Financials Sector UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.711

Change

+0.03 (+0.28)%

Market Cap

USD 0.42B

Volume

9.91K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.67 (+1.29%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.32 (+1.17%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.36 (+1.27%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.36%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.12 (+0.26%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.86 (+0.59%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.62 (+1.21%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.14 (+1.11%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+5.66 (+0.96%)

USD 80.38B

ETFs Containing ESIF:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.28% 82% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.28% 82% B 82% B
Trailing 12 Months  
Capital Gain 34.46% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.46% 85% B 84% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.01% 69% C- 67% D+
Dividend Return 10.01% 68% D+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.50% 49% F 59% D-
Risk Adjusted Return 80.07% 77% C+ 80% B-
Market Capitalization 0.42B 62% D 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.